Literature DB >> 8409316

Does ozone alleviate AIDS diarrhea?

M T Carpendale1, J Freeberg, J M Griffiss.   

Abstract

Five patients with acquired immune deficiency syndrome (AIDS) or AIDS-related complex (ARC) and intractable diarrhea were treated with daily colonic insufflations of medical ozone (oxygen/ozone mixture) for 21-28 days. The daily dose of ozone (O3) ranged from 2.7 to 30 mg. Three of the four patients whose diarrhea was of unknown etiology experienced complete resolution, and one patient had marked improvement. The fifth patient, whose diarrhea was due to Cryptosporidium, experienced no change. No consistent change in the absolute number of helper (CD4) or suppressor (CD8) lymphocytes was detected, and no obvious changes were seen in the PO2 or the results of routine hematologic and blood chemistry studies. Patients had mild to moderate local discomfort during ozone administration early in the course of treatment, but no adverse systemic effects were observed. The results of this series suggest that medical ozone administered by rectal insufflation is simple, safe, and effective. Should this simple treatment be used routinely to treat chronic intractable ARC/AIDS diarrhea?

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8409316     DOI: 10.1097/00004836-199309000-00010

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  5 in total

1.  Reversion by ozone treatment of acute nephrotoxicity induced by cisplatin in rats.

Authors:  Ricardo González; Aluet Borrego; Zullyt Zamora; Cheyla Romay; Frank Hernández; Silvia Menéndez; Teresita Montero; Enis Rojas
Journal:  Mediators Inflamm       Date:  2004-12       Impact factor: 4.711

Review 2.  Ozone therapy: a potential therapeutic adjunct for improving female reproductive health.

Authors:  Zaher Merhi; Bhavika Garg; Rajean Moseley-LaRue; Amber Ray Moseley; André Hugo Smith; John Zhang
Journal:  Med Gas Res       Date:  2019 Apr-Jun

Review 3.  The Role of Nrf2 in the Antioxidant Cellular Response to Medical Ozone Exposure.

Authors:  Mirco Galiè; Viviana Covi; Gabriele Tabaracci; Manuela Malatesta
Journal:  Int J Mol Sci       Date:  2019-08-17       Impact factor: 5.923

4.  A reasonable Approach for the Treatment of HIV Infection in the Early Phase with Ozonetherapy (Autohaemotherapy). How 'Inflammatory' Cytokines may have A therapeutic Role.

Authors:  V Bocci
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

5.  Ozone at low concentrations does not affect motility and proliferation of cancer cells in vitro.

Authors:  Manuela Costanzo; Alessandro Romeo; Barbara Cisterna; Laura Calderan; Paolo Bernardi; Viviana Covi; Gabriele Tabaracci; Manuela Malatesta
Journal:  Eur J Histochem       Date:  2020-04-02       Impact factor: 3.188

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.